Blog Posts - Sglt2 Inhibitor



FDA Adds Ketoacidosis Warnings To Diabetes Drugs Invokana, Farxiga, And Jardiance As Well As Other SGLT2 Inhibitors

This Follows October 2015 Safety Alert By Health Canada Concerning Increased Risks Of Kidney Problems (Posted by Tom Lamb at DrugInjuryWatch.com) In December 2015 the FDA issued a Drug Safety Communication concerning the risk of ketoacidosis, a serio...
by Drug Injury Watch on Dec 8, 2015


Trending Topics

Close